Pin your most used calculators here by clicking the star in the dropdown.
Calculadora O-RADS™ (Ultrassonografia)
Clinical Context & Background
O O-RADS™ US fornece um léxico padronizado e um sistema de estratificação de risco para massas ovarianas e anexiais. Atribui uma categoria de risco (O-RADS 1-5) baseada na morfologia, na "regra dos 3mm" para componentes sólidos e na vascularização (Color Score), que orienta o manejo clínico (observação, RM ou encaminhamento para especialista).
Referência: Andreotti RF, Timmerman D, Strachowski LM, et al. O-RADS US Risk Stratification and Management System: A Consensus Guideline from the ACR Ovarian-Adnexal Reporting and Data System Committee. Radiology. 2020;294(1):168-185.
Formula Logic
Árvore de decisão algorítmica (Morfologia → Modificadores de Tamanho/Vascularização)Reference Data
| Categoria | Risco de Malignidade | Manejo |
|---|---|---|
| O-RADS 1 | 0% | Fisiológico (Sem acompanhamento) |
| O-RADS 2 | < 1% | Quase Certamente Benigno (Vigilância) |
| O-RADS 3 | 1 - 10% | Risco Baixo (Especialista em Ginecologia / RM) |
| O-RADS 4 | 10 - 50% | Risco Intermediário (Ginecologia Oncológica / RM) |
| O-RADS 5 | ≥ 50% | Risco Alto (Encaminhamento ao Ginecologista Oncologista) |
Calculation verification history
Verified
Calculation verification history
Verified: Production browser revalidation
- Three source-backed O-RADS US v2022 cases passed through visible production controls at Categories 0, 1, and 5.
- The unsupported generic risk gauge was absent; no unexpected N/A, literal undefined value, stale control, or browser-console error was observed.
Case-level evidence is retained in validation/browser-revalidation/orads-2026-08-03.json.
: Local browser remediation
- All valid and invalid O-RADS outcomes now explicitly suppress the shared generic risk gauge so categories US 0-5 and their exact source intervals remain the only displayed framework.
- Ten source-backed cases passed through visible local browser controls across 11 submissions, covering categories 0-5, size equality, extraovarian upgrade, conditional validation, and reset/repeat behavior.
- The existing calculator-specific audit passed 182/182. Production status remains open until this commit is deployed and the public route is revalidated.
Local case-level remediation evidence is retained in validation/browser-production/orads.local-remediation.json.
: Production browser validation
- Ten source-backed cases were exercised on the public production route through visible browser controls; 10/10 case records passed their expected-versus-observed assertions across 11 visible submissions.
- Overall browser status: failed-ui-console. high: Every rendered O-RADS US 0-5 result displayed a generic Low Risk / Intermediate / High Risk gauge that is not the six-category source system and is nonsensical beside O-RADS US 0 Incomplete evaluation and O-RADS US 1 No malignancy-risk assignment. | medium: Production emitted minified React error #418 during the route load.
- Case-level inputs, expected and observed results, reset/repeat behavior, failure reproductions, and console evidence are retained in the production-browser evidence record.
Case-level production evidence is retained in validation/browser-production/orads.json.
: Full validation test
- 182/182 source, schema, branch, boundary, management, applicability, output, provenance, registry, report, and evidence assertions passed.
- This is implementation verification of the English route, not independent clinical validation; ES/PT/DE localized copies do not inherit this status.
: Correction
- Locked the route to the ACR November 2022 release and corrected the complete lexicon decision tree, strict validation, exact risk intervals, and conditional management.
- Removed favorable defaults, coercion, unknown fallthrough, incorrect solid branches, unilocular color-score overcalling, overlapping intervals, and universal size escalation.
Verification confirms the calculator implementation against the cited model; it is not independent clinical validation, regulatory approval, or medical advice.
Popular Tools
Evidence-based oncology decision support. Verify with clinical guidelines.